KALSIOM SAS Alternatives & Competitors
12 companies similar to KALSIOM SAS — Targeting calcium signaling to cure auto-immune diseases
Companies similar to KALSIOM SAS
Vastera
Pioneering innovative treatments for cardiovascular and cancer diseases through novel redo...
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Oncofactor Corporation
A Seattle-based innovator in cancer treatments, disrupting tumor-immune system signaling p...
CytoDyn
CytoDyn’s purpose is to help enhance the lives of patients with life-threatening diseases.
Vancouver, United States
Track all KALSIOM SAS competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
Upstream Bio
Developing treatments for inflammatory diseases
Waltham, United States
StromaCare
Stromacare is a pioneer in tumoral stroma immuno-modulation and develops a therapeutic mAb...
Lyon, France
Imugene Limited
Bringing Effective New Treatments And Options To Patients Who Need Them
Australia
AnaptysBio
Transforming patient health by delivering innovative immunology therapeutics.
San Diego, United States
Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
Boston, United States
Apollomics
We are a biopharmaceutical company committed to the discovery and development of mono- and...
Foster City, United State...
Biond Biologics Ltd
Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics f...
Israel
About KALSIOM SAS
KALSIOM SAS is a biotech company that was founded in April 2020 and is based in Brest, France. The company's slogan "Targeting calcium signaling to cure auto-immune diseases" encapsulates its focus on discovering and developing first-in-class therapies to treat auto-immune disorders (AID) involving B-cell dysfunction,...
Biotech, Auto-immune Diseases, B-cell Dysfunction, Monoclonal Antibodies, Calcium Signaling, Immunology, Therapeutic Antibodies, Lymphocytes, Immunotherapy, Drug Development, Medical Research, France, Startup, Investing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches KALSIOM SAS and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at KALSIOM SAS on 13 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
